We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Determinants of Compliance With Glaucoma Therapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01484392
First Posted: December 2, 2011
Last Update Posted: March 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Steven L. Mansberger, Legacy Health System
  Purpose
The purpose of this study is to determine which medical, demographic, and health belief factors are associated with glaucoma therapy compliance.

Condition
Open Angle Glaucoma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Determinants of Compliance With Glaucoma Therapy

Resource links provided by NLM:


Further study details as provided by Steven L. Mansberger, Legacy Health System:

Primary Outcome Measures:
  • Compliance with glaucoma medication at 1 month [ Time Frame: 1 month after enrollment ]
    Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

  • Compliance with glaucoma medication at 3 months [ Time Frame: 3 months after enrollment ]
    Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.


Enrollment: 60
Study Start Date: August 2006
Study Completion Date: December 2013
Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients diagnosed with open angle glaucoma.
Criteria

Inclusion Criteria:

  • open angle glaucoma
  • be well controlled on current medical therapy
  • be using a prostaglandin analogue
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01484392


Locations
United States, Oregon
Devers Eye Institute
Portland, Oregon, United States, 97210
Sponsors and Collaborators
Legacy Health System
Investigators
Principal Investigator: Steven L Mansberger, MD, MPH Legacy Health
  More Information

Responsible Party: Steven L. Mansberger, Associate Scientist, Legacy Health System
ClinicalTrials.gov Identifier: NCT01484392     History of Changes
Other Study ID Numbers: FWA00001280
First Submitted: November 30, 2011
First Posted: December 2, 2011
Last Update Posted: March 9, 2016
Last Verified: March 2016

Keywords provided by Steven L. Mansberger, Legacy Health System:
open angle glaucoma
compliance
adherence

Additional relevant MeSH terms:
Glaucoma
Glaucoma, Open-Angle
Ocular Hypertension
Eye Diseases